Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups

Autor: Massias, JS, Smith, EMD, Al-Abadi, E, Armon, K, Bailey, K, Ciurtin, C, Davidson, J, Gardner-Medwin, J, Haslam, K, Hawley, DP, Leahy, A, Leone, V, McErlane, F, Mewar, D, Modgil, G, Moots, R, Pilkington, C, Ramanan, AV, Rangaraj, S, Riley, P, Sridhar, A, Wilkinson, N, Beresford, MW, Hedrich, CM, Grp, UKJSLE Study

Publikováno v: Lupus
LUPUS
Massias, J S, Smith, E M D, Ramanan, A V & al., E 2020, ' Clinical and laboratory characteristics in juvenile-onset Systemic Lupus Erythematosus across age groups ', Lupus, vol. 29, no. 5, pp. 474-481 . https://doi.org/10.1177/0961203320909156

Background Systemic lupus erythematous (SLE) is a systemic autoimmune/inflammatory condition. Approximately 15–20% of patients develop symptoms before their 18th birthday and are diagnosed with juvenile-onset SLE (JSLE). Gender distribution, clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9508374809de2ad07a5892cac82d5c6
https://doi.org/10.1177/0961203320909156

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis

Autor: Shankar-Hari, M, Vale, CL, Godolphin, PJ, Fisher, D, Higgins, JPT, Spiga, F, Savovic, J, Tierney, J, Baron, G, Benbenishty, JS, Berry, LR, Broman, N, Cavalcanti, AB, Colman, R, De Buyser, SL, Derde, LPG, Domingo, P, Omar, SF, Fernandez-Cruz, A, Feuth, T, Garcia, F, Garcia-Vicuna, R, Gonzalez-Alvaro, I, Gordon, AC, Haynes, R, Hermine, O, Horby, PW, Horick, NK, Kumar, K, Lambrecht, BN, Landray, MJ, Leal, L, Lederer, DJ, Lorenzi, E, Mariette, X, Merchante, N, Misnan, NA, Mohan, SV, Nivens, MC, Oksi, J, Perez-Molina, JA, Pizov, R, Porcher, R, Postma, S, Rajasuriar, R, Ramanan, AV, Ravaud, P, Reid, PD, Rutgers, A, Sancho-Lopez, A, Seto, TB, Sivapalasingam, S, Soin, AS, Staplin, N, Stone, JH, Strohbehn, GW, Sunden-Cullberg, J, Torre-Cisneros, J, Tsai, LW, van Hoogstraten, H, van Meerten, T, Veiga, VC, Westerweel, PE, Murthy, S, Diaz, JV, Marshall, JC, Sterne, JAC, Pomar V., Benito N., WHO Rapid Evidence Appraisal COVID

Publikováno v: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

IMPORTANCE Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and harm. OBJECTIVE To estimate the association between administration of IL-6 antagonists compare

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a2c5c0ab547ccf2be0501d4122d08556
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4406

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

Autor: Ramanan, AV, Dick, AD, Jones, AP, McKay, A, Williamson, PR, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P, Benton, D, Edelsten, C, Beresford, MW, Grp, SYCAMORES

Publikováno v: Ramanan, A V, Dick, A D, Jones, A P, McKay, A, Williamson, P R, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P, Benton, D, Edelsten, C, Beresford, M W 2017, ' Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis ', New England Journal of Medicine, vol. 376, no. 17, pp. 1637-1646 . https://doi.org/10.1056/NEJMoa1614160
New England Journal of Medicine

BACKGROUND: Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, is effective in the treatment of juvenile idiopathic arthritis (JIA). We tested the efficacy of adalimumab in the treatment of JIA-associated uveitis.METHODS: In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccd45e3e04f21d1ed9f48277139b4aa
https://doi.org/10.1056/nejmoa1614160

ADALIMUMAB IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS: THE SYCAMORE TRIAL

Autor: Ramanan, AV, Dick, AD, Jones, AP, McKay, A, Williamson, PR, Compeyrot-Lacassagne, S, Hardwick, B, Hickey, H, Hughes, D, Woo, P, Benton, D, Edelsten, C, Beresford, MW

Publikováno v: ANNALS OF THE RHEUMATIC DISEASES

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::e11519fcb79a30a206a9c42f235788bc

Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Autor: Ravelli, A, Minoia, F, Davì, S, Horne, A, Bovis, F, Pistorio, A, Aricò, M, Avcin, T, Behrens, Em, De Benedetti, F, Filipovic, A, Grom, Aa, Henter, J-i, Ilowite, Nte, Jordan, Mb, Khubchandani, R, Kitoh, T, Lehmberg, K, Lovell, Dj, Miettunen, P, Nichols, Ke, Ozen, S, Schmid, Jp, Ramanan, Av, Russo, R, Schneider, R, Sterba, G, Uziel, Y, Wallace, C, Wouters, C, Wulffraat, N, Demirkaya, E, Brunner, Hi, Martini, A, Ruperto, N, Cron, Rq, Angioloni, S, Pallotti, C, Pesce, M, Rinaldi, M, Villa, L, Abinun, M, Aggarwal, A, Akikusa, J, Al-mayouf, Sm, Alessio, M, Anton, J, Apaz, Mt, Astigarraga, I, Ayaz, Na, Barone, P, Bica, B, Bolt, I, Breda, L, Chasnyk, V, Cimaz, R, Corona, F, Cuttica, R, D'Angelo, G, Davidsone, Z, De Cunto, C, De Inocencio, J, Eisenstein, E, Enciso, S, Espada, G, Fischbach, M, Frosch, M, Gallizzi, R, Gamir, Ml, Gao, Y-j, Griffin, T, Hashad, S, Hennon, T, Horneff, G, Huasong, Z, Huber, A, Insalaco, A, Ioseliani, M, Jelusic-drazic, M, Jeng, M, Kapovic, A, Kasapcopur, O, Kone-paut, I, De Oliveira Skf, Lattanzi, B, Lepore, L, Li, C, Lipton, Jm, Magni-manzoni, S, Maritsi, D, Mccurdy, D, Merino, R, Mulaosmanovic, V, Nielsen, S, Pal, P, Prahalad, S, Rigante, Donato, Rumba-rozenfelde, I, Magalhaes, Cs, Sanner, H, Sawhney, S, Sewairi, Wm, Shakoory, B, Shenoi, S, Clovis, As, Stanevicha, V, Stine, Kc, Susic, G, Sztajnbok, F, Takei, S, Tezer, H, Trauzeddel, R, Tsitsami, E, Unsal, E, Vougiouka, O, Weaver, Lk, Weiss, J, Weitzman, S, On Behalf Of The Pediatric Rheumatology International Trials Organization, Zletni M., The Childhood Arthritis & Rheumatology Research Alliance, The Pediatric Rheumatology Collaborative Study Group And The Histiocyte Society

Publikováno v: RMD Open, 2(1). BMJ Publishing Group
Ravelli, A, Minoia, F, Davì, S, Horne, A, Bovis, F, Pistorio, A, Aricò, M, Avcin, T, Behrens, E M, De Benedetti, F, Filipovic, A, Grom, A A, Henter, J-I, Ilowite, N T, Jordan, M B, Khubchandani, R, Kitoh, T, Lehmberg, K, Lovell, D J, Miettunen, P, Nichols, K E, Ozen, S, Pachlopnik Schmid, J, Ramanan, A V, Russo, R, Schneider, R, Sterba, G, Uziel, Y, Wallace, C, Wouters, C, Wulffraat, N, Demirkaya, E, Brunner, H I, Martini, A, Ruperto, N & Cron, R Q 2016, ' Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis ', RMD Open, vol. 2, no. 1, e000161 . https://doi.org/10.1136/rmdopen-2015-000161
Paediatrics Publications
RMD Open

OBJECTIVE: To identify which laboratory tests that change over time are most valuable for the timely diagnosis of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (sJIA).METHODS: A multistep process, based on a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcbe97ff3526cc9329e7045b4a36986
https://dspace.library.uu.nl/handle/1874/339609